[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339502-105":59,"doc-detail-339502-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","dlk1dio3-locus-upregulation-by-a-b-catenin-dependent-enhancer-drives-cell-proliferation-and-liver-tumorigenesis","DLK1/DIO3 locus upregulation by a b-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis","","DLK1/DIO3 locus expression is correlated with CTNNB1 (β-catenin) mutations in hepatocellular carcinoma (HCC) and hepatoblastoma (HB). The study determines how sustained β-catenin activation regulates DLK1/DIO3 transcription and the locus’s contribution to HB and HCC development in mouse models lacking Apc or Ctnnb1-exon 3 and in human CTNNB1-mutated hepatic cancer cells. A TCF-4/β-catenin-bound enhancer (DLK1-Wnt responsive element) promotes DLK1/DIO3 transcription, and CRISPR-Cas9 editing suppresses locus expression and slows tumor growth. Tumor inhibition reflects either increased FADD/caspase-3 cleavage or reduced FoxM1-dependent cell-cycle programs, supporting DLK1-WRE targeting as a therapeutic strategy for CTNNB1-mutant liver cancers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dlk1dio3-locus-upregulation-by-a-b-catenin-dependent-enhancer-drives-cell-proliferation-and-liver-tumorigenesis/339502/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dlk1dio3-locus-upregulation-by-a-b-catenin-dependent-enhancer-drives-cell-proliferation-and-liver-tumorigenesis/339502.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What enhancer element controls DLK1/DIO3 locus induction by β-catenin?","Question",{"text":112,"@type":113},"The DLK1-Wnt responsive element (DLK1-WRE) is bound by TCF-4/β-catenin complexes in an open conformation during sustained β-catenin activation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does CRISPR-Cas9 editing of the DLK1-WRE affect tumors?",{"text":117,"@type":113},"Editing impairs DLK1/DIO3 locus expression and slows tumor growth in CTNNB1-mutated tumor models.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanisms link DLK1/DIO3 suppression to reduced proliferation during liver tumorigenesis?",{"text":121,"@type":113},"Tumor growth inhibition results either from increased FADD expression with caspase-3 cleavage or from decreased expression of FoxM1-regulated cell-cycle actors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339502,1790133176,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Original Article  \nDLK1/DIO3 locus upregulation  \nby a b-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis  \nJulie Sanceau, 1,2,3 Lucie Poupel, 1,2,3,4 Camille Joubel, 1,2,3 Isabelle Lagoutte,5 Stefano Caruso, 1,3 Sandra Pinto, 1,2 Christèle Desbois-Mouthon, 1,2,3 Cécile Godard, 1,2,3 Akila Hamimi, 1,2,3 Enzo Montmory, 1,2,3 Cécile Dulary,6 Sophie Chantalat,6 Amélie Roehrig, 1,3 Kevin Muret,6 Benjamin Saint-Pierre,5 Jean-François Deleuze,6  \nSophie Mouillet-Richard, 1,3 Thierry Forné,7 Christophe F. Grosset,8,9 Jessica Zucman-Rossi, 1,3 Sabine Colnot, 1,2,3 and Angélique Gougelet 1,2,3  \n1Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, F-75006 Paris, France; 2Team « Oncogenic functions of beta-catenin signaling in the liver », Équipe labellisée par la Ligue Nationale contre le Cancer, F-75013 Paris, France; 3APHP, Institut du Cancer Paris CARPEM, F-75015 Paris, France; 4Inovarion, F-75005 Paris, France; 5University Paris Cité, Institut Cochin, INSERM, CNRS, F-75014 Paris, France; 6Centre National de Génotypage, Institut de Génomique, CEA, F-91057 Evry, France; 7IGMM, University Montpellier, CNRS, F-34293 Montpellier, France; 8University Bordeaux, INSERM, Biotherapy of Genetic Diseases, Inﬂammatory Disorders and Cancer, BMGIC, U1035, MIRCADE team, F-33076 Bordeaux, France; 9University Bordeaux, INSERM, Bordeaux Institute in Oncology, BRIC, U1312, MIRCADE team, F-33076 Bordeaux, France  \nThe CTNNB1 gene, encoding b-catenin, is frequently mutated in hepatocellular carcinoma (HCC, 􀀁 30%) and in hepatoblastoma (HB, >80%), in which DLK1/DIO3 locus induction is correlated with CTNNB1 mutations. Here, we aim to decipher how sustained b-catenin activation regulates DLK1/DIO3 locus expression and the role this locus plays in HB and HCC development in mouse models deleted forApc (ApcDhep) or Ctnnb1-exon 3 (b-cateninDExon3) and in human CTNNB1-mutated hepatic cancer cells. We identiﬁed an enhancer site bound by TCF-4/b-catenin complexes in an open conformation upon sustained b-catenin activation (DLK1-Wnt responsive element [WRE]) and increasing DLK1/DIO3 locus transcription in b-catenin-mutated human HB and mouse models. DLK1-WRE editing by CRISPR-Cas9 approach impaired DLK1/ DIO3 locus expression and slowed tumor growth in subcutaneous CTNNB1-mutated tumor cell grafts, ApcDhep HB and b-cateninDExon3 HCC. Tumor growth inhibition resulted either from increased FADD expression and subsequent caspase-3 cleavage in the ﬁrst case or from decreased expression of cell cycle actors regulated by FoxM1 in the others. Therefore, the DLK1/DIO3 locus is an essential determinant of FoxM1-dependent cell proliferation during b-catenin-driven liver tumorigenesis. Targeting the DLK1-WRE enhancer to silence the DLK1/DIO3 locus might thus represent an interesting therapeutic strategy to restrict tumor growth in primary liver cancers with CTNNB1 mutations.  \nINTRODUCTION  \nThe two most common primary liver tumors, hepatocellular carcinoma (HCC) in adults and hepatoblastoma (HB) in children, are both characterized by mutations in the Wnt/b-catenin pathway. So-  \nmatic point mutations in the CTNNB1 gene, encoding b-catenin, are encountered in approximately 30% of HCC 1 and CTNNB1 exon 3 deletions occur in more than 80% of HB.2,3 CTNNB1 mutations prevent b-catenin phosphorylation and its subsequent proteasomal degradation orchestrated by a complex containing APC, AXIN1, GSK3b, and CK1 . This leads to b-catenin stabilization and translocation into the nucleus, where, in hepatocytes, it interacts primarily with TCF-4 before recruitment at Wnt responsive elements (WREs) .4 This recruitment allows the regulation of a speciﬁc gene repertoire acting on metabolic and proliferative pathways.5,6 To ﬁnely tune its gene repertoire, b-catenin is able to cooperate with a plethora of histone modiﬁers and chromatin remodelers,7 numbers of them being mutated in HCC.8  \nIn HB, additional mutations can also affec","cbCaitCHTm9gAfAj","https://ap.wps.com/l/cbCaitCHTm9gAfAj","pdf",7307794,"English","# Introduction\n## Wnt/β-catenin pathway mutations in HCC and HB\n## Genomic imprinting and components of the DLK1/DIO3 locus\n## Epigenetic regulation via DMRs","[{\"question\":\"What enhancer element controls DLK1/DIO3 locus induction by β-catenin?\",\"answer\":\"The DLK1-Wnt responsive element (DLK1-WRE) is bound by TCF-4/β-catenin complexes in an open conformation during sustained β-catenin activation.\"},{\"question\":\"How does CRISPR-Cas9 editing of the DLK1-WRE affect tumors?\",\"answer\":\"Editing impairs DLK1/DIO3 locus expression and slows tumor growth in CTNNB1-mutated tumor models.\"},{\"question\":\"What mechanisms link DLK1/DIO3 suppression to reduced proliferation during liver tumorigenesis?\",\"answer\":\"Tumor growth inhibition results either from increased FADD expression with caspase-3 cleavage or from decreased expression of FoxM1-regulated cell-cycle actors.\"}]","DLK1/DIO3 locus upregulation by a b-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis | PDF",1790030634,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ceee32ba7c62981393af363a8913225.webp",983,1276,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6bb98c31b68669fe183244f4e55509d.webp",982,1275,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3c043203208e2ad40a62492419cf9f8.webp",981,1273,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db15ac0a2b4c05443c56ccb9560f3324.webp",980,1272]